Platelet function study in patients with sepsis
Part of Infections clinical trials.
This study looks at how platelets (small cells that help blood clot) behave in people with severe infections (sepsis). It explores a specific part of the immune system (inflammasome) linked to platelet activation, which may help develop better treatments for serious infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You (or a family member or legal representative) must agree to participate
- For most groups, you must have a confirmed infection (sepsis) with a positive lab test for bacteria or virus
- For one group, you must not have any infection (this group acts as a comparison)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether platelet transfusions help patients with sepsis and very low platelet counts recover better. If you or your loved one had sepsis, a low platelet count, and were in the ICU for at least two days, this trial may be relevant.
This study uses special blood testing to learn what is happening in the immune system during sepsis in children and how it may relate to organ injury. Your results may help doctors recognize and treat sepsis earlier and more accurately.
This study looks at different types (“endotypes”) of sepsis in adults to better understand what’s happening in the body and how patients may respond. You might be asked to provide information and samples as the study tries to sort sepsis into meaningful subgroups.
This study tests a new drug called romiplostim N01 to help raise platelet counts in patients with sepsis (a serious blood infection). Low platelets during sepsis can increase bleeding risk, and this drug may help prevent complications.
This study collects information from the blood of people in intensive care, to better understand what is happening in the body during sepsis or serious infection. It may help researchers find ways to monitor disease and improve care over time.
This study looks at simple blood tests (like levels of certain white blood cells and a protein called procalcitonin) to see if they can predict how well people with sepsis will do in the intensive care unit. It may help doctors understand your infection better.
Hear when a new Bacterial Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.